Obstetrics/Gynecology
RSSArticles
-
Where do pills fit in the family planning picture?
In national statistics, the pill continues to lead the pack, with 25.9% of contracepting women (9.7 million women) reporting its use. Female sterilization was listed by 25.1% (9.4 million women), followed by the male condom (15.3%, 5.8 million women) and long-acting reversible contraception (11.6%, 4.4 million women).
-
Should oral contraceptives move over the counter? Readers speak out
Most participants in the Contraceptive Technology Update Contraception Survey say they support moving oral contraceptives over the counter. Almost 50% say they would support OTC availability of progestin-only pills, while 32% say they would support similar availability of combined hormonal pills.
-
Focus on the contraceptive implant — Insert it in your family planning practice
About 30% of participants in the 2015 Contraceptive Technology Update Contraception Survey reported 25 or more implant insertions in the past year, with 14% saying they inserted 11 to 24 devices.
-
Survey profile
The 2015 Contraceptive Technology Update Contraception Survey monitors contraceptive trends and family planning issues among readers. Results were tallied and analyzed by AHC Media in Atlanta, which publishes CTU and dozens of other healthcare newsletters and sourcebooks and presents webinars and conferences.
-
Survey results show use of LARC continues to rise
About 46% of participants in the 2015 Contraceptive Technology Update Contraception Survey say they have seen “dramatically more” women choosing long-acting reversible contraceptive methods such as the intrauterine device and contraceptive implant in the last year.
-
Recurrence Rate for Placental Abruption
A study from the Netherlands involving more than 1 million patients has shown that recurrence of placental abruption happens more frequently in those patients whose first abruption occurred at term and/or in their first pregnancy, as well as in those with a history of hypertension.
-
Hormone Replacement Therapy Controversies: Have We Harmed Women?
The interpretation of hormone replacement therapy in postmenopausal women has varied dramatically before and after the publication of the Women’s Health Initiative study in 2002. New studies question the validity of the conclusions reached by the investigators.
-
Molecular Diagnostics: A Step Forward in Breast Cancer Treatment?
Use of a gene-expression assay to predict prognosis may reduce the need for adjuvant chemotherapy in some women with early stage invasive breast cancer.
-
New Data on Atraumatic Tenaculum Pain Scores
ABSTRACT & COMMENTARY: There was no difference in pain scores between the standard single-tooth tenaculum and the atraumatic vulsellum tenaculum.
-
Congenital syphilis on rise — What you can do
Are you testing your pregnant patients for syphilis at the first prenatal visit and treating them if infected? If not, it’s time to step up your efforts. An analysis from the CDC shows that after years of decline, the number of congenital syphilis cases reported in the United States increased between 2012 and 2014.